However, validating this hypothesis has proven challenging as most studies investigating the clinicopathological features of NSCLC and PD‐L1 expression have primarily focused on patients from North America, Europe, and Asia, while Latin American and African populations have been notably underrepresented.20, 21. The gene discussed is CD274; the disease is non-small cell lung carcinoma.